Deal News

  • 8 January 2019

    Takeda completes $62bn Shire acquisition

    Japan-based Takeda Pharmaceutical has officially completed the acquisition of UK headquartered Shire for a total consideration of $62bn. This makes Takeda one of the top ten pharmaceutical companies in the...

  • 8 January 2019

    Lilly to acquire Loxo Oncology in deal valued at $8bn

    Eli Lilly has signed a definitive agreement to acquire Loxo Oncology, a biopharmaceutical firm focussed on genomically defined cancers, for a cash consideration of around $8bn, or $235 per share.

Go Top